Capitol Hill Update: More medical device hearings slated for this week
April 11, 2011 by MassDevice staff
Twin hearings in the House and Senate aim to dissect how medical devices get to market through the FDA.
A pair of hearings on Capitol Hill this week aim to peer closely at how the medical device industry interacts with regulators at the FDA.
The higher chamber kicks things off April 13 with the Senate Special Committee on Aging's hear, "A Delicate Balance: FDA and the Reform of the Medical Device Approval Process." No agenda or witness list has been released about the nature of the hearing.
Similar entries
- Login to post comments
-
Permalink
FDA Database Search
RECENT BLOG POSTS
- Funding R&D: High prices, overuse a failed strategy
- FDA's role in promoting women's health
- New partnership to boost use of GMDN codes for medical devices
- FDA's modern "Corps of Discovery" in China
- Consumers lose in latest FDA user fee bill; COI restraints disappear
- Gamification
- Cool technology of the week
- A new day: Interim thoughts on the 2012 Heart Rhythm Society scientific sessions
- When a child loses milestones, consider sleep EEG studies
- Red or blue pill for payment reform? Both won't work
NEWS
EuroPCR: Warnings on TAVI in replacing surgically implanted prosthetic valves
Transcatheter aortic valve implantation proves successful in reinforcing failed valve prosthetics,...
Weight loss: Surgery triggers rare metabolic wasting disease | MassDevice.com On Call
A rare but deadly genetic mutation that prevents the body from absorbing protein can be set off by...
Medical device tax: Ohio's industry pushes repeal while GOP group gets hyper-political
Ohio-based medical device makers meet with local legislators to discuss efforts to repeal the...
MassDevice.com +3 | The top 3 med-tech stories for May 15, 2012.
Boston Scientific's Lotus TAVI system minimizes leakage in an early trial, St. Jude Medical gains on...
Electromed CEO Robert Hansen retires after 20 years at the helm | Personnel Moves
Electromed founder, chairman & CEO Robert Hansen announces his retirement after 20 years leading...
